LII vs UTHR · P/E 27, rev $1.20B vs P/E 20, rev $1.56B
Lennox International Inc (LII) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Lennox International Inc (LII) is a building products & equipment company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LII revenue for 2025-12-31 was $1.20B. Net income was $142.5M. Revenue was down 77.6% from 2024-12-31 to 2025-12-31. LII currently screens at market cap $21.44B and trailing P/E 26.9.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
LII currently screens at market cap $21.44B and trailing P/E 26.9. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the LII and UTHR stock pages for the full models.
Not investment advice.